Plasma and vessel wall lipoprotein lipase have different roles in atherosclerosis

Journal of Lipid Research

Volumn 41, Issue 4, 2000, Pages 521-531

  Clee, Susanne M ^a   Bissada, Nagat ^a   Miao, Fudan ^a   Miao, Li ^a   Marais, A David ^b   Henderson, Howard E ^c   Steures, Pieternel ^a   McManus, Janet ^a   McManus, Bruce ^a   LeBoeuf, Renee C ^d   Kastelein, John J P ^e   Hayden, Michael R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c Children's Hospitals   (South Africa)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

apoE deficient mice; C57BL 6; HDL; Lipoprotein retention; Triglycerides

Indexed keywords

APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL WALL; DISEASE PREDISPOSITION; DYSLIPIDEMIA; ENZYME ACTIVITY; GENOTYPE; LIPID ANALYSIS; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; AORTA; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; LIPOPROTEIN LIPASE; LIPOPROTEINS, HDL; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MICE, TRANSGENIC; TRIGLYCERIDES;

EID: 0033994696     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Brunzell, J. D. 1995. Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome. In The Metabolic Basis of Inherited Disease. C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle, editors. McGraw-Hill Inc., New York. 1913-1932.
2. Murthy, V., P. Julien, and C. Gagné. 1996. Molecular pathobiology of the human lipoprotein lipase gene. Pharmacol Ther. 70: 101-135.
3. Goldberg, I. J. 1996. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J. Lipid Res. 37: 693-707.
4. Wilson, D. E., M. Emi, P-H. Iverius, A. Hata, L. L. Wu, E. Hillas, R. R. Williams, and J-M. Lalouel. 1990. Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation. J. Clin. Invest. 86: 735-750.
5. Bijvoet, S., S. E. Gagné, S. Moorjani, H. E. Henderson, J-C. Fruchart, J. Dallongeville, P. Alaupovic, M. Prins, J. J. P. Kastelein, and M. R. Hayden. 1996. Alterations in plasma lipoproteins and apolipoproteins before the age of 40 in heterozygotes for lipoprotein lipase deficiency. J. Lipid Res. 37: 640-650.
6. Nordestgaard, B. G., S. Abildgaard, H. H. Wittrup, R. Steffensen, G. Jensen, and A. Tybjærg-Hansen. 1997. Heterozygous lipoprotein lipase deficiency. Frequency in the general population, effect on plasma lipid levels, and risk of ischemic heart disease. Circulation. 96: 1737-1744.
7. Gaziano, J. M., C. H. Hennekens, C. J. O'Donnell, J. L. Breslow, and J. E. Buring. 1997. Fasting triglycerides, high density lipoprotein, and risk of myocardial infarction. Circulation. 96: 2520-2525.
8. McGill, H. C., Jr., A. McMahan, G. T. Malcom, M. C. Oalmann, and J. P. Strong. 1997. Effects of serum lipoproteins and smoking on atherosclerosis in young men and women. Arterioscler. Thromb. Vasc. Biol. 17: 95-106.
9. Mack, W. J., R. M. Krauss, and H. N. Hodis. 1996. Lipoprotein subclasses in the Monitored Atherosclerosis Regression Study (MARS). Treatment effects and relation to coronary angiographic progression. Arterioscler. Thromb. Vasc. Biol. 16: 697-704.
10. Alaupovic, P., W. J. Mack, C. Knight-Gihson, and H. N. Hodis. 1997. The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial. Arterioscler. Thromb. Vasc. Biol. 17: 715-722.
11. Mann, W. A., N. Meyer, W. Weber, F. Rinninger, H. Greten, and U. Beisiegel. 1995. Apolipoprotein E and lipoprotein lipase coordinately enhance binding and uptake of chylomicrons by human hepatocytes. Eur. J. Clin. Invest. 25: 880-882.
12. Skottova, N., R. Savonen, A. Lookene, M. Hultin, and G. Olivecrona. 1995. Lipoprotein lipase enhances removal of chylomicrons and chylomicron remnants by the perfused rat liver. J. Lipid Res. 36: 1334-1344.
13. Mulder, M., P. Lombardi, H. Jansen, T. J. C. van Berkel, R. R. Frants, and L. M. Havekes. 1993. Low density lipoprotein receptor internalizes low density and very low density lipoproteins that are bound to heparan sulfate proteoglycans via lipoprotein lipase. J. Biol. Chem. 268: 9369-9375.
14. 2-macroglobulin receptor is induced by the C-terminal domain of lipoprotein lipase. J. Biol. Chem. 269: 18001-18006.
15. Ylä-Herttuala, S., B. A. Lipton, M. E. Rosenfeld, I. J. Goldberg, D. Steinberg, and J. L. Witztum. 1991. Macrophages and smooth muscle cells express lipoprotein lipase in human and rabbit atherosclerotic lesions. Proc. Natl. Acad. Sci. USA. 88: 10143-10147.
16. O'Brien, K. D., D. Gordon, S. Deeb, M. Ferguson, and A. Chait. 1992. Lipoprotein lipase is synthesized by macrophage-derived foam cells in human coronary atherosclerotic plaques. J. Clin. Invest. 89: 1544-1550.
17. Renier, G., E. Skamene, J. B. DeSanctis, and D. Radzioch. 1993. High macrophage lipoprotein lipase expression and secretion are associated in inbred murine strains with susceptibility to atherosclerosis. Arteriosler. Thromb. 13: 190-196.
18. Rumsey, S. C., J. C. Obunike, Y. Arad, R. J. Deckelbaum, and I. J. Goldberg. 1992. Lipoprotein lipase-mediated uptake and degradation of low density lipoproteins by fibroblasts and macrophages. J. Clin. Invest. 90: 1504-1512.
19. Lindqvist, P., A-M. Ostlund-Lindqvist, J. L. Witztum, D. Steinberg, and J. A. Little. 1983. The role of lipoprotein lipase in the metabolism of triglyceride-rich lipoproteins by macrophages. J. Biol. Chem. 258: 9086-9092.
20. Aviram, M., E. L. Bierman, and A. Chait. 1988. Modification of low density lipoprotein by lipoprotein lipase or hepatic lipase induces enhanced uptake and cholesterol accumulation in cells. J. Biol. Chem. 263: 15416-15422.
21. Eisenberg, S., E. Sehayek, T. Olivecrona, and I. Vlodavsky. 1992. Lipoprotein lipase enhances binding of lipoproteins to heparan sulfate on cell surfaces and extracellular matrix. J. Clin. Invest. 90: 2013-2021.
22. Saxena, U., M. G. Klein, T. M. Vanni, and I. J. Goldberg. 1992. Lipoprotein lipase increases low density lipoprotein retention by subendothelial cell matrix. J. Clin. Invest. 89: 373-380.
23. Edwards, I. J., I. J. Goldberg, J. S. Parks, H. Xu, and W. D. Wagner. 1993. Lipoprotein lipase enhances the interaction of low density lipoproteins with artery-derived extracellular matrix proteoglycans. J. Lipid Res. 34: 1155-1163.
24. Rutledge, J. C., M. M. Woo, A. A. Rezai. L. K. Curtiss, and I. J. Goldberg. 1997. Lipoprotein lipase increases lipoprotein binding to the artery wall and increases endothelial layer permeability by formation of lipolysis products. Circ. Res. 80: 819-828.
25. Rutledge, J. C., and I. J. Goldberg. 1994. Lipoprotein lipase (LpL) affects low density lipoprotein (LDL) flux through vascular tissue: evidence that LpL increases LDL accumulation in vascular tissue. J. Lipid Res 35: 1152-1160.
26. Tabas, I., Y. Li, R. W. Brocia, S. W. Xu, T. L. Swenson, and K. J. Williams. 1993. Lipoprotein lipase and sphingomyelinase synergistically enhance the association of atherogenic lipoproteins with smooth muscle cells and extracellular matrix. A possible mechanism for low density lipoprotein and lipoprotein (a) retention and macrophage foam cell formation. J. Biol. Chem. 268: 20419-20432.
27. Hendriks, W. L., H. van der Boom, L. C. van Vark, and L. M. Havekes. 1996. Lipoprotein lipase stimulates the binding and uptake of moderately oxidized low-density lipoprotein by J774 macrophages. Biochem. J. 314: 563-568.
28. Corey, J. E., and D. B. Zilversmit. 1977. Effect of cholesterol feeding on arterial lipolytic activity in the rabbit. Atherosclerosis. 27: 201-212.
29. Obunike, J. C., S. Paka, S. Pillarisetti, and I. J. Goldberg. 1997. Lipoprotein lipase can function as a monocyte adhesion protein. Arterioscler. Thromb. Vasc. Biol. 17: 1414-1420.
30. Mamputu, J-C., A-C. Desfaits, and G. Renier. 1997. Lipoprotein lipase enhances human monocyte adhesion to aortic endothelial cells. J. Lipid Res. 38: 1722-1729.
31. Coleman, T., R. L. Seip, J. M. Gimble, D. Lee, N. Maeda, and C. F. Semenkovich. 1995. COOH-terminal disruption of lipoprotein lipase in mice is lethal in homozygotes, but heterozygotes have elevated triglycerides and impaired enzyme activity. J. Biol. Chem. 270: 12518-12525.
32. Liu, M-S., R. C. LeBoeuf, H. Henderson, L. W. Castellani, A. J. Lusis, Y. Ma, I. J. Forsythe, H. Zhang, E. Kirk, J. D. Brunzell, and M. R. Hayden. 1994. Alteration of lipid profiles in plasma of transgenic mice expressing human lipoprotein lipase. J. Biol. Chem. 269: 11417-11424.
33. Clee, S. M., H. Zhang, N. Bissada, L. Miao, E. Ehrenborg, P. Benlian, G. X. Shen, A. Angel, R. C. Le Boeuf, and M. R. Hayden. 1997. Relationship between lipoprotein lipase and high density lipoprotein cholesterol in mice: modulation by cholesteryl ester transfer protein and dietary status. J. Lipid Res. 38: 2079-2089.
34. Paigen, B., A. Morrow, P. A. Holmes, D. Mitchell, and R. A. Williams. 1987. Quantitative assessment of atherosclerotic lesions in mice. Atheroslerosis. 68: 231-240.
35. Semenkovich, C. F., T. Goleman, and A. Daugherty. 1998. Effects of heterozygous lipoprotein lipase deficiency on diet-induced atherosclerosis in mice. J. Lipid Res. 39: 1141-1151.
36. Babaev, V. R., S. Fazio, L. A. Gleaves, K. J. Carter, C. F. Semenkovich, and M. F. Linton. 1999. Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo. J. Clin. Invest. 103: 1697-1705.
37. Shimada, M., S. Ishibashi, T. Inaba, H. Yagyu, K. Harada, J-I. Osuga, K. Ohashi, Y. Yazaki, and Y. Nobuhiro. 1996. Suppression of diet-induced atherosclerosis in low density lipoprotein receptor knockout mice overexpressing lipoprotein lipase. Proc. Natl. Acad. Sci. USA. 93: 7242-7246.
38. Yagyu, H., S. Ishibashi, Z. Chen, J-I. Osuga, M. Okazaki, S. Perrey, T. Kitamine, M. Shimada, K. Ohashi, K. Harada, F. Shionoiri, N. Yahagi, T. Gotoda, Y. Yazaki, and N. Yamada. 1999. Overexpressed lipoprotein lipase protects against atherosclerosis in apolipoprotein E knockout mice. J. Lipid Res. 40: 1677-1685.
39. Ashbourne Excoffon, K. J. D., G. Liu, L. Miao, J. E. Wilson, B. M. McManus, C. F. Semenkovich, T. Goleman, P. Benoit, N. Duverger, D. Branellec, P. Denefle, M. R. Hayden, and M. E. S. Lewis. 1997. Correction of hypertriglyceridemia and impaired fat tolerance in lipoprotein lipase-deficient mice by adenovinis-mediated expression of human lipoprotein lipase. Arterioscler. Thromb. Vasc. Biol. 17: 2532-2539.
40. Auwerx, J., P. Leroy, and K. Schoonjans. 1992. Lipoprotein lipase: recent contributions from molecular biology. Crit. Rev. Clin. Lab. Sci. 29: 243-268.
41. Ma, Y., H. E. Henderson, M. R. V. Murthy, G. Roederer, M. V. Monsalve, L. A. Clarke, T. Normand, P. Julien, C. Gagné, M. Lambert, J. Davignon, P. J. Lupien, J. Brunzell, and M. R. Hayden. A mutation in the human lipoprotein lipase gene as the most common cause of familial chylomicronemia in French Canadians. N. Engl. J. Med. 324: 1761-1766.
42. Peacock, R. E., A. Hamsten, P. Nilsson-Ehle, and S. E. Humphries. 1992. Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden. Atherosclerosis. 97: 171-185.
43. Jemaa, R., F. Fumeron, O. Poirier, L. Lecerf, A. Evans, D. Arveiler, G. Luc, J-P. Cambou, J-M. Bard, J-C. Fruchart, M. Apfelbaum, F. Cambien, and L. Tiret. 1990. Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. J. Lipid Res. 36: 2141-2146.
44. Kastelein, J. J. P., B. E. Groenemeyer, D. M. Hallman, H. Henderson, P. W. A. Reymer, S. K. Gagné, H. Jansen, J. C. Seidell, D. Kromhout, J. W. Jukema, A. V. G. Bruschke, K. Boerwinkle, and M. R. Hayden. 1998. The Asn9 variant of lipoprotein lipase is associated with the -93G promoter mutation and an increased risk of coronary artery disease. Clin. Genet. 53: 27-33.
45. Humphries, S. E., V. Nicaud, J. Margalef, L. Tiret, and P. J. Talmud. 1998. Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and lasting and postprandial plasma triglycerides. The European Atherosclerosis Research Study (EARS). Arterioscler: Thromb. Vasc. Biol. 18: 526-534.
46. Jukema, J. W., A. J. van Boven, B. Groenemeijer, A. H. Zwinderman, J. H. C. Reiber, A. V. G. Brtischke, J. A. Henneman, G. P. Molhoek, T. Bruin, H. Jasnen, F. Gagné, M. R. Hayden, and J. J. P. Kastelein. 1996. The Asp9Asn mutation in the lipoprotein lipase gene is associated with increased progression of coronary atherosclerosis. Circulation. 94: 1913-1918.
47. Wittekoek, M. E., S. N. Pimstone, P. W. A. Reymer, L. Feuth, G-J. Botma, J. C. Delesche, M. Prins, M. R. Hayden, and J. J. P. Kastelein. 1998. A common mutation in the lipoprotein lipase gene (N291S) alters the lipoprotein phenotype and risk for cardiovascular disease in patients with familial hypercholesterolemia. Circulation. 97: 729-735.
48. Wittrup, H. H., A. Tybjaerg-Hansen, S. Abildgaard, R. Steffensen, P. Schnohr, and B. G. Nordestgaard. 1997. A common substitution (Asn291Ser) in lipoprotein lipase is associated with increased risk of ischemic heart disease. J. Clin. Invest. 99: 1606-1613.
49. Mattu, R. K., E. W. A. Needham, R. Morgan, A. Rees, A. K. Hackshaw, J. Stocks, P. C. Elwood, and D. J. Galton. 1994. DNA variants at the LPL, gene locus associated with angiographically defined severity of atherosclerosis and serum lipoprotein levels in a Welsh population. Arterioscler. Thromb. 14: 1090-1097.
50. Fisher, R. M., F. Mailly, R. E. Peacock, A. Hamsten, M. Seed, J. S. Yudkin, U. Beisiegel, G. Feussner, G. Miller, S. E. Humphries, and P. J. Talmud. 1995. Interaction of the lipoprotein lipase asparagine 291-→serine mutation with body mass index determines elevated plasma triacylglycerol concentrations: a study in hyperlipidemic subjects, myocardial infarction survivors, and healthy adults. J. Lipid Res. 36: 2104-2112.
51. Zhang, Q., J. Cavanna, B. R. Winkelman, B. Shine, W. Gross, W. Marz, and D. J. Gallon. 1995. Common genetic variants of lipoprotein lipase that relate to lipid transport in patients with premature coronary artery disease. Clin. Genet. 48: 293-298.
52. Gerdes, C., R. M. Fisher, V. Nicaud, J. Boer, S. E. Humphries, P. J. Talmud, and O. Faergeman. 1997. Lipoprotein lipase variants D9N and N291S are associated with increased plasma triglyceride and lower high-density lipoprotein cholesterol concentrations. Studies in the fasting and postprandial states: the European Atherosclerosis Research Studies. Circulation. 96: 733-740.
53. Mailly, F., R. M. Fisher, V. Nicaud, L-A. Luong, A. E. Evans, P. Marques-Vidal, G. Luc, D. Arveiler, J. M. Bard, O. Poirier, P. J. Talmud, and S. K. Humphries. 1996. Association between the LPL-D9N mutation in the lipoprotein lipase gene and plasma lipid traits in myocardial infarction survivors from the ECTIM study. Atherosclerosis. 122:21-28.
54. Mailly, F., Y. Tugrul, P. W. A. Reymer, T. Bruin, M. Seed, B. E. Groenemeijer, A. Asplund-Carlson, D. Vallance, A. F. Winder, G. J. Miller, J. J. P. Kastelein, A. Hamsten, G. Olivecrona, S. E. Humphries, and P. J. Talmud. 1995. A common variant in the gene for lipoprotein lipase (Asp9→Asn). Functional implications and prevalence in normal and hypertriglyceridemic subjects. Arterioscler. Thromb. Vasc. Biol. 15: 468-478.
55. Zhang, H., H. Henderson, S. E. Gagné, S. M. Clee, L. Miao, G. Liu, and M. R. Hayden. 1996. Common sequence variants of lipoprotein lipase: standardized studies of in vitro expression and catalytic function. Biochem. Biophys. Acta. 1302: 159-166.
56. Ginzinger, D. G., S. M. Clee, J. Dallongeville, M. E. S. Lewis, H. E. Henderson, E. Bauje, Q. R. Rogers, D. R. Jensen, R. H. Eckel, R. Dyer, S. Innis, B. Jones, J-C. Fruchart, and M. R. Hayden. 1999. Lipid and lipoprotein analysis of cats with lipoprotein lipase deficiency. Eur. J. Clin. Invest. 29: 17-26.
57. Rinninger, F., T. Kaiser, W. A. Mann, N. Meyer, H. Greten, and U. Beisiegel. 1998. Lipoprotein lipase mediates an increase in the selective uptake of high density lipoprotein-associated cholesteryl esters by hepatic cells in culture. J. Lipid Res. 39: 1335-1348.
58. 3-associated cholesteryl esters by mouse peritoneal macrophages. J. Lipid Res. 38: 239-253.
59. van Barlingen, H. H. J. J., H. de Jong, D. W. Erkelens, and T. W. A. de Bruin. 1996. Lipoprotein lipase-enhanced binding of human triglyceride-rich lipoproteins to heparan sulfate: modulation by apolipoprotein E and apolipoprotein C. J. Lipid Res. 37: 754-763.